November 2025
1. OOI H, Asai Y, Kondo Y, Tashiro T, et al
   The Albumin-Bilirubin-Fibrosis-4 Score for Predicting Teicoplanin-Induced Abnormal Liver Enzyme Levels in Patients Undergoing Therapeutic Drug Monitoring: A Multicentral Retrospective Cohort Study.
   Ann Pharmacother. 2025;59:978-988.
   

   >> Share

   
   February 2025
2. OOI H, Asai Y, Koriyama Y, Takahashi M, et al
   Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study.
   Ann Pharmacother. 2025;59:117-126.
   

   >> Share

   
   September 2024
3. ESTEVES AM, Buchfellner MC, Holmes BM, Berndsen JA, et al
   Impact of a Divided Phenobarbital Load and Taper Compared With Lorazepam Symptom Triggered Therapy in Hospitalized Patients.
   Ann Pharmacother. 2024;58:896-905.
   

   >> Share

   
   
4. KESSEL KM, Olson LM, Kruse DA, Lyden ER, et al
   Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal.
   Ann Pharmacother. 2024;58:877-885.
   

   >> Share

   
   April 2023
5. WONG A
   Comment: Comparison of 2-Bag Versus 3-Bag N-Acetylcysteine Regimens for Pediatric Acetaminophen Toxicity.
   Ann Pharmacother. 2023;57:505.
   

   >> Share

   
   March 2023
6. DANIEL-MCCALLA SN, Parbuoni KA, Leonard J, Morgan JA, et al
   Medical Outcomes of Acute Aspirin Single Substance Poisoning in Pediatric Patients.
   Ann Pharmacother. 2023 Mar 28:10600280231159898. doi: 10.1177/10600280231159898.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share